Exabis Library
Welcome to the e-CCO Library!
P346: Decreasing disparities in and use of systemic corticosteroid and disparities in use among paediatric patients with Crohn disease in a multicentre collaborative
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P346: Dietary practices and beliefs among parents of children with inflammatory bowel disease: preliminary results
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P346: Influence of diagnostic delay on ulcerative colitis characteristics at disease onset
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P346: Small bowel permeability improves with nutritional therapy in mild-to-moderate active paediatric Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P346: Soluble transferrin receptor and its relation to anaemia in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P346: The application of indocyanine green during robotic surgery for IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P347 Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P347: Evaluation of step up therapy in patients with early ulcerative colitis: a prospective cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P347: Identification of a cut-off for persistent anti-infliximab antibodies as a predictor of response to infliximab monotherapy
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P347: New-onset autoimmune disorders, primarily psoriasis, in anti-TNF biologic exposed paediatric patients: the DEVELOP experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P347: Practical recommendations for the collection of the patient-reported outcomes included in the Health Outcomes Observatory (H2O) core data set for patients with inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P347: Sarcopenia is a poor prognostic factor for endoscopic outcomes in patients with Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P347: Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P347: Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P348 Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P348: 3D reconstructions in complex fistulising perianal Crohn’s disease to aid decision-making
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P348: Correlation between Mayo endoscopic score and validated histological score in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P348: Disease trajectories in ulcerative colitis: Early identification of patients with endoscopic remission at Week 52
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P348: Novel model of care: the effect of a combined inflammatory bowel disease and antenatal clinic
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P348: Perception of cancer risk in inflammatory bowel disease-associated dysplasia and management practice is influenced by colonoscopy experience and workplace affiliation: results of an international clinician survey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM